HIGHLIGHTS
- who: Commentary et al. from the (Nutrition, Metabolisms and Cancer), Rennes, France have published the Article: Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor, in the Journal: Gut Microbes and Health Research Programme, of September/14,/2022
SUMMARY
Aggressive anticancer therapies sweep away proliferating cells, thereby releasing the competitive pressure from quiescent cancer stem_cells endowed with detoxification, survival and metabolic fitness. The work by Xiang et al suggests that anticancer therapy should combine conventional antiproliferative and tumour mass-reducing approaches (including biotherapy and immunotherapy), with strategies to prevent the development of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.